24. ELECTROSHOCK: THE
"NEW, IMPROVED" PSYCHIATRIC THERAPY
Electroshock treatment
is a form of psychiatric therapy born in the age of lobotomies and made famous
in "One Flew Over the Cuckoo's Nest." Electrodes are placed on a patient's
temples and electricity is shot through the brain, inducing an epileptic-like
seizure that is supposed to cure mental illness. After years of abuse, highlighted
by the "dark days" of the 1950s when hospitals turned into "shock
mills" and patients were forced to undergo shock treatments that often turned
them into zombies, electroshock treatment seemed destined to disappear along with
lobotomies.
Today, however, hospitals are secretly bringing back electroshock
therapy. To introduce the new shock therapy, now called electro-convulsive therapy
(ECT), the American Psychiatric Association (APA) held a December 1989 press conference
where psychiatrists announced ECT has become "safe and effective." The
most significant change is that ECT is now applied to only one side of the brain
- the more creative, emotional side - rather than both sides, as in the past.
Proponents
say ECT is now on the rise because of its effectiveness. "It's a life-saver,"
says Dr. Glen Peterson, of Providence Hospital, in Oakland, California. "In
the face of all the negative criticism, we haven't been able to get away from
the fact that ECT is a very effective treatment." The hospital's informational
brochure says "ECT is an exceptionally effective medical treatment, helping
90 percent of the patients who take it. Most patients remain well for many months
afterwards."
As ECT returns, the question of brain damage has disappeared
from most discussion of the treatment. The APA's new 217-page report on ECT doesn't
even mention the issue, except to say that doctors needn't include brain damage
as a risk they mention to patients. Meanwhile, former shock patients, patients'
rights advocates and doctors say the treatment doesn't really cure problems -
but may cause some serious ones. "It's a quick-fix treatment that causes
brain damage, but it doesn't work," says neurologist John Friedberg of Berkeley,
author of the book "Shock Treatment is Not Good for Your Brain."
Critics
charge that one reason that ECT is becoming more popular is because it is immensely
lucrative. The average ECT patient will stay in the hospital for about a month,
at a cost of about $500 a day; when the cost of treatment is added, the bill comes
to about $20,000. Insurance companies and Medicare support ECT by paying for longer
hospital stays for psychiatric patients who receive the treatment compared to
those on medications or undergoing psychotherapy.
To support increased use
of ECT, the APA has requested that the Food and Drug Administration reclassify
the machine used to shock patients from Class III to Class II. The shock machine
was put in Class III in 1979, after the FDA's Neurological Device Classification
Panel identified eight risks to health in ECT, including brain damage and memory
loss. Class II is for low or moderate-risk devices.
Since the APA has been
able to maintain a low media profile on its efforts to bring back electroshock
therapy, the number of patients receiving such therapy has been on the rise, and
it is now estimated that 100,000 people, mostly middle-aged, white females, receive
it annually.
SSU CENSORED RESEARCHER: TONY WEEKS
SOURCE: THE SAN FRANCISCO
BAY GUARDIAN, 520 Hampshire St., San Francisco, CA 94110-1417, DATE: 4/18/90
TITLE: "Electroshock's Quiet Comeback"
AUTHOR: VINCE BIELSKI
COMMENTS:
Investigative journalist Vince Bielski feels it is important for the general
public to know about the resurgence of electroshock therapy because as it becomes
"a more common practice, tens of thousands of patients will be receiving
shock therapy each year in the U.S., and many won't have full knowledge of its
effects. The psychiatric associations consistently play up its potential benefits
(short-term recovery from severe depression) and play down and perhaps cover up
its risks (brain damage, learning disabilities and memory loss). The responsibility
to inform patients falls on the shoulders of the media and the health advocacy
groups. I wrote my story to inform a very vulnerable consumer, the psychiatric
patient, and it carried the simple warning, `beware'." Bielski believes his
article in the Bay Guardian was the first to announce the resurgence of shock
therapy, although, he added, the New York Times did the story a few months later
using several of his sources and even the same headline but it was not as critical
of the therapy as Bielski's. He said that the limited coverage given the issue
tended to benefit conservatives in the psychiatric establishment who tend to be
the practitioners of shock therapy. "They are on a crusade to convince other
psychiatrists and the public that mental illness is a biochemical disorder treated
best with electroshock. To this end they have produced popular videos and several
articles in magazines touting electroshock. The only real check on this campaign
to bring electroshock back is the media, because those who consider themselves
victims of electroshock tend to either go into hiding, or if they do speak out,
they often lack credibility due to their illness." As a result of Bielski's
efforts, electroshock therapy is not expected to become a common practice again
without at least some public debate. His investigative report sparked a debate
among politicians, psychiatrists, and activists whether to ban or restrict the
use of electroshock in the city. As Bielski noted "The controversy (resulting
in part from his article) ... illustrates the important role of the media in exposing
potentially harmful activities and forcing politicians to find solutions."